Aamer Mumtaz

We are a group of Business Angels, established in Portugal to support and fund the internationalization of Brazilian start-ups, willing to come to Europe via Portugal. Our main goal is to deliver a great Business Angels experience by empowering those involved in the entrepreneurial world. We truly believe that sharing knowledge is the key ingredient to success. Our group of angels is very diversified, transparent, open-minded and involved. We want our startups to be the best version of themselves, in order for them to bring innovative solutions to our societys problems and demands. So, if you are a star-up in Brazil, with more than one year of revenues, a great team, a relevant opportunity and need help, you came to the right place. Applications on https://gust.com/organizations/coreangels-atlantic/funding_applications/responses/sessions/new

We are a group of Business Angels, established in Portugal to support and fund the internationalization of Brazilian start-ups, willing to come to Europe via Portugal. Our main goal is to deliver a great Business Angels experience by empowering those involved in the entrepreneurial world. We truly believe that sharing knowledge is the key ingredient to success. Our group of angels is very diversified, transparent, open-minded and involved. We want our startups to be the best version of themselves, in order for them to bring innovative solutions to our societys problems and demands. So, if you are a star-up in Brazil, with more than one year of revenues, a great team, a relevant opportunity and need help, you came to the right place. Applications on https://gust.com/organizations/coreangels-atlantic/funding_applications/responses/sessions/new

Significant advances in medical sciences have led to drug and chemical innovations that have yielded huge reductions in morbidity and helped increase life expectancy from ~31 years in 1900 to ~73 years in 2019. Despite this progress, infectious diseases remain a huge and growing burden. Climate change, urbanization, social inequality, migration, industrial livestock production, all these factors continue to lead to frightening increase in infectious diseases, even as growing resistance to antibiotics continue to erode the value of our existing arsenal. And while vaccines and antibody therapies demonstrate significant potential, there has been little progress in the development of vaccine and antibody therapies against microorganisms. ID-Antigens is a novel biotech firm that aims to address this challenge. We utilize advanced Mass Spectrometry(MS)-based proteomics approaches in a unique and comprehensive antigen discovery platform for unbiased exploration of mostly uncharacterized microbial proteomes, with the goal of developing vaccines and therapeutic antibodies against critical bacterial diseases. Our innovative approach has already successfully identified S protein, a promising antigen candidate for a Group A Streptococcus vaccine development (GAS, Streptococcus pyogenes). Our antigen-focused research, while initially focused on combating bacterial pathogens, has potential applicability to other pathogenic microorganism, such as viruses and fungi, as well as cancer.

Since 1990, BDC has been a trusted advisor to the nation’s largest health systems, academic medical centers, physician organizations, and health plans. We partner with executives, boards and physicians through major transformations, bringing deep insights, a collaborative approach and pioneering strategies with proven results. Through years of experience, we have identified six pillars for hospitals and health systems to achieve success through healthcare reform. Our consulting services align with these foundational elements: health enterprise strategy, provider network development, organization design & development, population health management, payer / provider innovation, strategic pricing and cost repositioning, and consumer and digital health. BDC’s fresh thinking and practical approach have offered significant competitive advantages for leading health systems across the US. Our senior healthcare strategists, consultants, and analysts have deep-rooted expertise in healthcare services, and we are dedicated to building rigorous, successful processes to address the challenges of today’s dynamic market. Pioneering Strategies. Practical Approach. Constructive Change.

Accenture helps the world’s leading enterprises reinvent by building their digital core and unleashing the power of AI to create value at speed for organizations across industries. Our strategy is to be the reinvention partner of choice for our clients and lead in the safe, widespread adoption of AI, and to be the most client-focused, AI-enabled, great place to work in the world. We bring together the talent of our approximately 786,000 people with proprietary assets and platforms, deep process and industry expertise, and leading ecosystem relationships to deliver end-to-end solutions and measurable outcomes at scale. Through our Reinvention Services, we offer broad expertise across Cybersecurity, Digital Core, Finance, Industry and Enterprise, Song, Supply Chain and Engineering, and Talent, with advanced capabilities in AI and Data, Industry and Process, and Technology. We serve approximately 9,000 clients and generated approximately $70 billion in FY25 revenue. Visit us at accenture.com. This LinkedIn company page is moderated. When engaging with Accenture, we encourage everyone to: - Use common courtesy and be respectful of others. - Create your own original content and avoid content that you know to be fraudulent. - Never repost someone elses copyrighted work, unless you have permission. - Never post personal, identifying, or confidential information. We reserve the right to delete comments or posts we deem to be: - Profane, obscene, inappropriate, offensive, abusive material. - Spam, repeated comments and commercial messages and personal advertisements. - Discriminatory or that contain hateful speech of any kind regarding age, gender, race, religion, nationality, sexual orientation, gender identity or disability. - Threats; personal attacks; abusive, defamatory, derogatory, or inflammatory language; or stalking or harassment of any individual, entity or organization. - False, inaccurate, libelous, or otherwise misleading in any way.

We believe in the power of ingenuity to build a positive human future. As strategies, technologies, and innovation collide, we create opportunity from complexity. Our diverse teams of experts combine innovative thinking and breakthrough technologies to progress further, faster. Our clients adapt and transform, and together we achieve enduring results. We are about 4,000 strategists, innovators, designers, consultants, digital experts, scientists, engineers, and technologists. And we have deep expertise in consumer and manufacturing, defence and security, energy and utilities, financial services, government and public services, health and life sciences, and transport. Our teams operate globally from offices across the UK, Ireland, US, Nordics, and Netherlands. PA. Bringing Ingenuity to Life.